九州大学研究活動表彰受賞

2010.11   九州大学生体防御医学研究所  

公益信託　外科学研究助成基金

2009.9   外科学会   マイクロRNAを介した癌転移機構解明に関するシンポジウムおよび技術指導

第18回日本消化器癌発生学会 最優秀賞

2007.11   日本消化器癌発生学会   【課題名】消化器癌における炎症発癌機構と癌抑制遺伝子FHITとの関係

かなえ研究奨励賞

2007.9  

平成19年度第1回海外派遣事業(助成)

2007.2   がん特定領域国際交流委員会  

平成18年度文部科学大臣表彰若手科学者賞

2006.3   文部科学省   癌抑制遺伝子FHITの臨床応用に関する研究

日本膵臓病学会研究奨励賞

2005.1   日本膵臓病学会  

日本癌学会研究奨励賞

2004.10   日本癌学会  

日本がん転移学会研究奨励賞

2004.7   日本がん転移学会  

国際トラベルグラント賞(助成)

2003.10   九州大学  

第12回日本がん転移学会　優秀演題賞

2003.6   日本がん転移学会  

上原記念研究助成

2002.9   上原記念研究   研究助成

かなえ研究奨励賞

2002.9  

Cancer-specific chromosome alterations in the constitutive fragile region FRA3B.

Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M, Huebner K and Croce CM

Proc Natl Acad Sci (U.S.A)   96 ( 13 )   7456 - 7461   1999.6

Case report:A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy. Reviewed International journal

Ohmura H, Tobo T, Ando Y, Masuda T, Mimori K, Akashi K, Baba E.

Front Oncol.   14   1340419 - 1340419   2024.5

Field experiment of a telesurgery system using a surgical robot with haptic feedback. Reviewed International journal

Ota M, Oki E, Nakanoko T, Tanaka Y, Toyota S, Hu Q, Nakaji Y, Nakanishi R, Ando K, Kimura Y, Hisamatsu Y, Mimori K, Takahashi Y, Morohashi H, Kanno T, Tadano K, Kawashima K, Takano H, Ebihara Y, Shiota M, Inokuchi J, Eto M, Yoshizumi T, Hakamada K, Hirano S, Mori M.

Surg Today.   54 ( (4) )   375 - 381   2024.4

Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis. Reviewed International journal

Hashimoto M, Kojima Y, Sakamoto T, Ozato Y, Nakano Y, Abe T, Hosoda K, Saito H, Higuchi S, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Hata T, Nagayama S, Kagawa K, Goto Y, Utou M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Takahashi K, Niida A, Hirose H, Hayashi S, Koseki J, Fukuchi S, Murakami K, Yoshizumi T, Kadomatsu K, Tobo T, Oda Y, Uemura M, Eguchi H, Doki Y, Mori M, Oshima M, Shibata T, Suzuki Y, Shimamura T, Mimori K.

105102. - 105102.   2024.4

Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer. Reviewed International journal

Nakano T, Takao S, Dairaku K, Uno N, Low SA, Hashimoto M, Tsuda Y, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Eto K, Ikegami T, Fukunaga Y, Niida A, Nagayama S, Mimori K.

Cancer Sci.   2024.3

Liquid biopsy for breast cancer and other solid tumors: a review of recent advances. Reviewed International journal

Ohmura H, Hanamura F, Okumura Y, Ando Y, Masuda T, Mimori K, Akashi K, Baba E.

Breast Cancer.   2024.3

Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer. Reviewed International journal

Hashimoto M, Masuda T, Nakano Y, Tobo T, Saito H, Koike K, Takahashi J, Abe T, Ando Y, Ozato Y, Hosoda K, Higuchi S, Hisamatsu Y, Toshima T, Yonemura Y, Hata T, Uemura M, Eguchi H, Doki Y, Mori M, Mimori K.

Cancer Sci   2024.3

A rare case of liver regenerative and non-neoplastic lesion resembling a well-differentiated hepatocellular carcinoma. Reviewed International journal

Hirose K, Toshima T, Tobo T, Kai S, Hirakawa M, Higuchi S, Ofuchi T, Hosoda K, Yonemura Y, Hisamatsu Y, Masuda T, Aishima S, Mimori K.

Surg Case Rep.   10 ( (1) )   30 - 30   2024.2

What Are Risk Factors for Graft Loss in Patients Who Underwent Simultaneous Splenectomy During Living-donor Liver Transplantation? Reviewed International journal

Toshima T, Harada N, Itoh S, Tomiyama T, Toshida K, Morita K, Nagao Y, Kurihara T, Tomino T, Kosai-Fujimoto Y, Mimori K, Yoshizumi T.

Transplantation.   2024.2

Real-time telementoring with 3D drawing annotation in robotic surgery. Reviewed International journal

Nakanoko T, Oki E, Ota M, Ikenaga N, Hisamatsu Y, Toshima T, Kanno T, Tadano K, Kawashima K, Ohuchida K, Morohashi H, Ebihara Y, Mimori K, Nakamura M, Yoshizumi T, Hakamada K, Hirano S, Ikeda N, Mori M.

Surg Endosc.   37 ( (12) )   9676 - 9683   2023.12

Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma. Reviewed International journal

Kosai K, Masuda T, Kitagawa A, Tobo T, Ono Y, Ando Y, Takahashi J, Haratake N, Kohno M, Takenaka T, Yoshizumi T, Mimori K.

Ann Surg Oncol.   30 ( (12) )   7538 - 7548   2023.11

Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers. Reviewed International journal

Kobayashi Y, Niida A, Nagayama S, Saeki K, Haeno H, Takahashi KK, Hayashi S, Ozato Y, Saito H, Hasegawa T, Nakamura H, Tobo T, Kitagawa A, Sato K, Shimizu D, Hirata H, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Mizuno S, Kawazu M, Kohsaka S, Ueno T, Mano H, Ishihara S, Uemura M, Mori M, Doki Y, Eguchi H, Oshima M, Suzuki Y, Shibata T, Mimori K.

Br J Cancer.   129 ( (7) )   1105 - 1118   2023.10

Fibrolamellar hepatocellular carcinoma: a case report and gene analysis. Reviewed International journal

Watanabe A, Harimoto N, Saito H, Kawabata-Iwakawa R, Seki T, Muranushi R, Hoshino K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Ikota H, Ishige T, Mimori K, Shirabe K.

Surg Case Rep.   9 ( (1) )   168. - 168.   2023.9

Telesurgery and telesurgical support using a double-surgeon cockpit system allowing manipulation from two locations. Reviewed International journal

Oki E, Ota M, Nakanoko T, Tanaka Y, Toyota S, Hu Q, Nakaji Y, Nakanishi R, Ando K, Kimura Y, Hisamatsu Y, Mimori K, Takahashi Y, Morohashi H, Kanno T, Tadano K, Kawashima K, Takano H, Ebihara Y, Shiota M, Inokuchi J, Eto M, Yoshizumi T, Hakamada K, Hirano S, Mori M.

Surg Endosc.   37 ( (8) )   6071 - 6078   2023.8

Hot spring bathing practices have a positive effect on mental health in Japan. Reviewed International journal

Takeda M, Nakamura H, Otsu H, Mimori K, Maeda T, Managi S.

Heliyon.   9 ( (9) )   2023.8

Successful multidisciplinary treatment with complete response to atezolizumab plus bevacizumab in a 90-year-old patient with hepatocellular carcinoma recurrence. Reviewed International journal

Hosoda K, Toshima T, Takahashi J, Yonemura Y, Hisamatsu Y, Hirose K, Masuda T, Motomura Y, Abe T, Ando Y, Dairaku K, Nakano Y, Hashimoto M, Hiraki Y, Soejima Y, Yoshizumi T, Mimori K.

Int Cancer Conf J.   12 ( (4) )   274 - 278   2023.7

Trousseau's Syndrome with Advanced Neuroendocrine Carcinoma of Colon: A Case Report. Reviewed International journal

Ohmura H, Tobo T, Mimori K, Baba E, Horiuchi T.

Case Rep Oncol.   16 ( (1) )   484 - 490   2023.7

The comprehensive review of gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) from diagnosis and treatment. Reviewed International journal

Iwatsuki M, Matsumoto C, Mimori K, Baba H.

Ann Gastroenterol Surg.   7 ( (5) )   725 - 732   2023.7

Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action. Reviewed International journal

Mol Oncol.   2023.4

Convergent genomic diversity and novel BCAA metabolism in intrahepatic cholangiocarcinoma. Invited Reviewed International journal

Kitagawa A, Osawa T, Noda M, Kobayashi Y, Aki S, Nakano Y, Saito T, Shimizu D, Komatsu H, Sugaya M, Takahashi J, Kosai K, Takao S, Motomura Y, Sato K, Hu Q, Fujii A, Wakiyama H, Tobo T, Uchida H, Sugimachi K, Shibata K, Utsunomiya T, Kobayashi S, Ishii H, Hasegawa T, Masuda T, Matsui Y, Niida A, Soga T, Suzuki Y, Miyano S, Aburatani H, Doki Y, Eguchi H, Mori M, Nakayama KI, Shimamura T, Shibata T, Mimori K.

British Journal of Cancer   128 ( 12 )   2206 - 2217   2023.3

Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer. Reviewed International journal

Masuda T, Ueo H, Okumura Y, Kai Y, Ando Y, Masuguchi K, Kitagawa M, Kitagawa A, Hayashi N, Tsuruda Y, Hisamatsu Y, Suehiro S, Ohmura H, Fujiyoshi K, Tanaka F, Mimori K.

Cancer Genomics Proteomics.   20 ( 2 )   182 - 194   2023.3

Novel and classic approaches for managing gastrointestinal cancers. Reviewed International journal

Mimori K.

Ann Gastroenterol Surg.   7 ( 2 )   196 - 197   2023.3

Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer. Reviewed International journal

Nambara S, Masuda T, Hirose K, Hu Q, Tobo T, Ozato Y, Kurashige J, Hiraki Y, Hisamatsu Y, Iguchi T, Sugimachi K, Oki E, Yoshizumi T, Mimori K.

Cancer Genomics Proteomics.   20 ( 1 )   30 - 39   2023.1

Prediction of tissue-of-origin of early stage cancers using serum miRNomes. Reviewed International journal

6. Matsuzaki J, Kato K, Oono K, Tsuchiya N, Sudo K, Shimomura A, Tamura K, Shiino S, Kinoshita T, Daiko H, Wada T, Katai H, Ochiai H, Kanemitsu Y, Takamaru H, Abe S, Saito Y, Boku N, Kondo S, Ueno H, Okusaka T, Shimada K, Ohe Y, Asakura K, Yoshida Y, Watanabe SI, Asano N, Kawai A, Ohno M, Narita Y, Ishikawa M, Kato T, Fujimoto H, Niida S, Sakamoto H, Takizawa S, Akiba T, Okanohara D, Shiraishi K, Kohno T, Takeshita F, Nakagama H, Ota N, Ochiya T; Project Team for Development and Diagnostic Technology for Detection of miRNA in Body Fluids.

JNCI Cancer Spectr.   7 ( 1 )   pkac080   2023.1

Mutated genes on ctDNA detecting postoperative recurrence presented reduced neoantigens in primary tumors in colorectal cancer cases. Reviewed International journal

Nagayama S, Kobayashi Y, Fukunaga M, Sakimura S, Sugimachi K, Sasaki S, Masuda T, Mafune KI, Oshima M, Shibata T, Suzuki Y, Mimori K.

Sci Rep   13 ( 1 )   1366   2023.1

Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer. Reviewed International journal

Ozato Y, Kojima Y, Kobayashi Y, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Kagawa K, Goto Y, Utou M, Fukunaga M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Niida A, Hirose H, Hayashi S, Koseki J, Oki E, Fukuchi S, Murakami K, Tobo T, Nagayama S, Uemura M, Sakamoto T, Oshima M, Doki Y, Eguchi H, Mori M, Iwasaki T, Oda Y, Shibata T, Suzuki Y, Shimamura T, Mimori K.

Cell Rep.   42 ( 1 )   111929   2023.1

A case of malignant phyllodes tumor that responded to pazopanib and developed pneumothorax. Reviewed International journal

Ohmura H, Masuda T, Mimori K, Baba E, Horiuchi T.

Int Cancer Conf J.   12 ( 1 )   31 - 35   2022.8

Identification of serum microRNAs as potential diagnostic biomarkers for detecting precancerous lesions of gastric cancer. Reviewed International journal

Otsu H, Nambara S, Hu Q, Hisamatsu Y, Toshima T, Takeishi K, Yonemura Y, Masuda T, Oki E, Mimori K.

Ann Gastroenterol Surg   7 ( 1 )   63 - 70   2022.8

The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy. Reviewed International journal

Hirata H, Niida A, Kakiuchi N, Uchi R, Sugimachi K, Masuda T, Saito T, Kageyama SI, Motomura Y, Ito S, Yoshitake T, Tsurumaru D, Nishimuta Y, Yokoyama A, Hasegawa T, Chiba K, Shiraishi Y, Du J, Miura F, Morita M, Toh Y, Hirakawa M, Shioyama Y, Ito T, Akimoto T, Miyano S, Shibata T, Mori M, Suzuki Y, Ogawa S, Ishigami K, Mimori K.

Cancer Res.   81 ( (19) )   4926 - 4938   2022.7

Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin. Reviewed International journal

Shimizu D, Taniue K, Matsui Y, Haeno H, Araki H, Miura F, Fukunaga M, Shiraishi K, Miyamoto Y, Tsukamoto S, Komine A, Kobayashi Y, Kitagawa A, Yoshikawa Y, Sato K, Saito T, Ito S, Masuda T, Niida A, Suzuki M, Baba H, Ito T, Akimitsu N, Kodera Y, Mimori K.

Cancer Gene Ther.   29 ( (5) )   428 - 436   2022.5

Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements. Reviewed International journal

Ueo H, Minoura I, Ueo H, Gamachi A, Kai Y, Kubota Y, Doi T, Yamaguchi M, Yamashita T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Masuda T, Urano Y, Mori M, Mimori K.

Sci Rep.   12 ( (1) )   8520 - 8520   2022.5

Artificial intelligence-assisted drug repurposing via "chemical-induced gene expression ranking". Reviewed International journal

Masuda T, Mimori K.

Patterns (N Y)   3 ( (4) )   100470 - 100470   2022.4

GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein. Reviewed International journal

Koike K, Masuda T, Sato K, Fujii A, Wakiyama H, Tobo T, Takahashi J, Motomura Y, Nakano T, Saito H, Matsumoto Y, Otsu H, Takeishi K, Yonemura Y, Mimori K, Nakagawa T.

Cancer Sci.   113 ( (1) )   156 - 169   2022.1

Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma. Reviewed International journal

Takahashi J, Masuda T, Kitagawa A, Tobo T, Nakano Y, Abe T, Ando Y, Kosai K, Kobayashi Y, Matsumoto Y, Yoshizumi T, Mori M, Mimori K.

Oncology.   100 ( (2) )   101 - 113   2022.1

Nano-scale physical properties characteristic to metastatic intestinal cancer cells identified by high-speed scanning ion conductance microscope. Reviewed International journal

Wang D, Sun L, Okuda S, Yamamoto D, Nakayama M, Oshima H, Saito H, Kouyama Y, Mimori K, Ando T, Watanabe S, Oshima M.

Biomaterials.   Epub ( Epub )   Epub - Epub   2022.1

Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA. Reviewed International journal

Sakano Y, Noda T, Kobayashi S, Kitagawa A, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Gotoh K, Asaoka T, Tanemura M, Umeshita K, Mimori K, Doki Y, Eguchi H.

Dig Dis Sci.   Epub ( Epub )   Epub - Epub   2021.10

Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence. Reviewed International journal

Fukunaga M, Mimori K, Masuda T, Hu Q, Yamada K, Mori M.

Surg Today.   51 ( (10) )   1671 - 1681   2021.10

Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA. Reviewed International journal

Sunami K, Bando H, Yatabe Y, Naito Y, Takahashi H, Tsuchihara K, Toyooka S,Mimori K, Kohsaka S, Uetake H, Kinoshita I, Komine K, Takeda M, Hayashida T, Tamura K, Nishio K, Yamamoto N; Working Group of a Joint Task Force of Three Academic Societies for the Promotion of Cancer Genomic Medicine.

Cancer Sci.   112 ( (9) )   3911 - 3917   2021.9

Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy. Reviewed International journal

Masuda T, Niizeki O, Niizeki T, Fujiyoshi K, Ando Y, Niizeki H, Mimori K.

Case Rep Oncol.   14 ( (3) )   1261 - 1265   2021.9

Single-cell DNA and RNA sequencing reveals the dynamics of intra-tumor heterogeneity in a colorectal cancer model. Reviewed International journal

Ono H, Arai Y, Furukawa E, Narushima D, Matsuura T, Nakamura H, Shiokawa D, Nagai M, Imai T, Mimori K, Okamoto K, Hippo Y, Shibata T, Kato M.

BMC Biol.   19 ( (1) )   207 - 207   2021.9

Radiology- and gene-based risk stratification in small renal cell carcinoma: A preliminary study. Reviewed International journal

Takao S, Ushijima Y, Motomura Y, Sakamoto K, Hirakawa M, Nishie A, Mimori K, Yamashita Y, Tsutsumi T, Ishigami K.

PLoS One.   16 ( (9) )   e0256471 - e0256471   2021.9

Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer. Reviewed International journal

Hu Q, Masuda T, Koike K, Sato K, Tobo T, Kuramitsu S, Kitagawa A, Fujii A, Noda M, Tsuruda Y, Otsu H, Kuroda Y, Ito S, Oki E, Mimori K.

Sci Rep.   11 ( (1) )   19178 - 19178   2021.9

Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells. Reviewed International journal

Kuramitsu S, Masuda T, Hu Q, Tobo T, Yashiro M, Fujii A, Kitagawa A, Abe T, Otsu H, Ito S, Oki E, Mori M, Mimori K.

Cancer Genomics Proteomics.   18 ( (4) )   521 - 529   2021.7

Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma. Invited Reviewed International journal

Morine Y, Utsunomiya T, Saito Y, Yamada S, Imura S, Ikemoto T, Kitagawa A, Kobayashi Y, Takao S, Kosai K, Mimori K, Tanaka Y, Shimada M.

Oncotarget   11 ( 52 )   4803 - 4812   2021.5

Modeling colorectal cancer evolution. Reviewed International journal

Niida A, Mimori K, Shibata T, Miyano S.

J Hum Genet   2021.5

Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer. Reviewed International journal

Hu Q, Nonaka K, Wakiyama H, Miyashita Y, Fujimoto Y, Jogo T, Hokonohara K, Nakanishi R, Hisamatsu Y, Ando K, Kimura Y, Masuda T, Oki E, Mimori K, Oda Y, Mori M.

Cancer Med   10 ( 9 )   3129 - 3138   2021.5

Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer. Reviewed International journal

Kobayashi Y, Masuda T, Fujii A, Shimizu D, Sato K, Kitagawa A, Tobo T, Ozato Y, Saito H, Kuramitsu S, Noda M, Otsu H, Mizushima T, Doki Y, Eguchi H, Mori M, Mimori K.

Cancer Sci   2021.5

Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT. Reviewed International journal

Hu Q, Masuda T, Kuramitsu S, Tobo T, Sato K, Kidogami S, Nambara S, Ueda M, Tsuruda Y, Kuroda Y, Ito S, Oki E, Mori M, Mimori K.

PLoS One   159 ( 10 )   e0241140.   2021.5

Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence. Reviewed International journal

Fukunaga M, Mimori K, Masuda T, Hu Q, Yamada K, Mori M.

Surg Today   2021.4

The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer. Reviewed International journal

Fujii A, Masuda T, Iwata M, Tobo T, Wakiyama H, Koike K, Kosai K, Nakano T, Kuramitsu S, Kitagawa A, Sato K, Kouyama Y, Shimizu D, Matsumoto Y, Utsunomiya T, Ohtsuka T, Yamanishi Y, Nakamura M, Mimori K.

Cancer Sci   112 ( 4 )   1655 - 1668   2021.4

Impaired tumor immune response in metastatic tumors is a selective pressure for　neutral evolution in CRC cases Reviewed International journal

Sakimura S, Nagayama S, Fukunaga M, Hu Q, Kitagawa A, Kobayashi Y, Hasegawa　T, Noda M, Kouyama Y, Shimizu D, Saito T, Niida A, Tsuruda Y, Otsu H, Matsumoto　Y, Uchida H, Masuda T, Sugimachi K, Sasaki S, Yamada K, Takahashi K, Innan H,　Suzuki Y, Nakamura H, Totoki Y, Mizuno S, Ohshima M, Shibata T, Mimori K.

17 ( (1) )   e1009113. - e1009113.   2021.1

Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases. Reviewed International journal

Sakimura S, Nagayama S, Fukunaga M, Hu Q, Kitagawa A, Kobayashi Y, Hasegawa T, Noda M, Kouyama Y, Shimizu D, Saito T, Niida A, Tsuruda Y, Otsu H, Matsumoto Y, Uchida H, Masuda T, Sugimachi K, Sasaki S, Yamada K, Takahashi K, Innan H, Suzuki Y, Nakamura H, Totoki Y, Mizuno S, Ohshima M, Shibata T, Mimori K.

PLoS Genet   17 ( 1 )   e1009113.   2021.1

Depressed Colorectal Cancer: A New Paradigm in Early Colorectal Cancer. Reviewed International journal

Kudo SE, Kouyama Y, Ogawa Y, Ichimasa K, Hamada T, Kato K, Kudo K, Masuda T, Otsu H, Misawa M, Mori Y, Kudo T, Hayashi T, Wakamura K, Miyachi H, Sawada N, Sato T, Shibata T, Hamatani S, Nemoto T, Ishida F, Niida A, Miyano S, Oshima M, Ogino S, Mimori K.

Clin Transl Gastroenterol.   11 ( 12 )   e00269.   2020.12

A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer. Reviewed International journal

26 ( 12 )   2420 - 2423   2020.12

The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling. Reviewed International journal

Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y,Shimura T, Ivkovic TC, Cruz De Los Santos M, Anfossi S, Shimizu M, Shah MY, Ling H, Shen P, Multani AS, Pardini B, Burks JK, Katayama H, Reineke LC, Huo L, Syed M, Song S, Ferracin M, Oki E, Fromm B, Ivan C, Bhuvaneshwar K, Gusev Y, Mimori K, Menter D, Sen S, Matsuyama T, Uetake H, Vasilescu C, Kopetz S, Parker-Thornburg J, Taguchi A, Hanash SM, Girnita L, Slaby O, Goel A, Varani G, Gagea M, Li C, Ajani JA, Calin GA.

Gastroenterology   159 ( 6 )   2146 - 2162   2020.12

miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells. Reviewed International journal

Mukohyama J, Isobe T, Hu Q, Hayashi T, Watanabe T, Maeda M, Yanagi H, Qian X, Yamashita K, Minami H, Mimori K, Sahoo D, Kakeji Y, Suzuki A, Dalerba P, Shimono Y.

Cancer Res.   79 ( 20 )   5151 - 5158   2020.10

YAP1 Activation Drives Immediate Onset of Cervical Carcinoma In Situ in Mice. Reviewed International journal

Nishio M, To Y, Maehama T, Aono Y, Otani J, Hikasa H, Kitagawa A, Mimori K, Sasaki T, Nishina H, Toyokuni S, Lydon JP, Nakao K, Wah Mak T, Kiyono T, Katabuchi H, Tashiro H, Suzuki A.

Cancer Sci.   Epub ( Epub )   Epub   2020.7

The Expression Level of PD-L1 (CD274) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer. Reviewed International journal

Masuda T, Noda M, Kitagawa A, Hu Q, Fujii A, Ito S, Kosai K, Ando Y, Matsumoto Y, Ohtsu H, Uchida H, Ohno S, Mimori K.

Anticancer Res.   40 ( 7 )   3733 - 3742   2020.7

Genetic landscape of external auditory canal squamous cell carcinoma. Reviewed International journal

Sato K, Komune N, Hongo T, Koike K, Niida A, Uchi R, Noda T, Kogo R, Matsumoto N, Yamamoto H, Masuda M, Oda Y, Mimori K, Nakagawa T.

Cancer Sci.   Epub ( Epub )   Epub   2020.6

F3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma. Reviewed International journal

Kidogami S, Iguchi T, Sato K, Yoshikawa Y, Hu Q, Nambara S, Komatsu H, Ueda M, Kuroda Y, Masuda T, Mori M, Doki Y, Mimori K.

Anticancer Res.   40 ( 5 )   2941 - 2946   2020.5

Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer. Reviewed International journal

Ito S, Masuda T, Noda M, Hu Q, Shimizu D, Kuroda Y, Eguchi H, Tobo T, Utsunomiya T, Mimori K.

Oncology.   98 ( 7 )   501 - 511   2020.5

A unified simulation model for understanding the diversity of cancer evolution. Reviewed International journal

Niida A, Hasegawa T, Innan H, Shibata T, Mimori K, Miyano S.

PeerJ.   8   e8842.   2020.4

Drug repositioning in cancer: The current situation in Japan. Reviewed International journal

Masuda T, Tsuruda Y, Matsumoto Y, Uchida H, Nakayama KI, Mimori K.

Cancer Sci.   111 ( 4 )   1039 - 1046   2020.4

Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients. Reviewed International journal

Noda M, Masuda T, Ito S, Tobo T, Kitagawa A, Hu Q, Shimizu D, Eguchi H, Etoh T, Ohno S, Inomata M, Mimori K.

Ann Surg Oncol.   Epub ( Epub )   Epub   2020.3

YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. Reviewed International journal

Omori H, Nishio M, Masuda M, Miyachi Y, Ueda F, Nakano T, Sato K, Mimori K, Taguchi K, Hikasa H, Nishina H, Tashiro H, Kiyono T, Mak TW, Nakao K, Nakagawa T, Maehama T, Suzuki A.

Sci Adv.   6 ( 12 )   eaay3324   2020.3

KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma. Reviewed International journal

Kitagawa A, Masuda T, Takahashi J, Tobo T, Noda M, Kuroda Y, Hu Q, Kouyama Y, Kobayashi Y, Kuramitsu S, Sato K, Fujii A, Yoshikawa Y, Wakiyama H, Shimizu D, Tsuruda Y, Eguchi H, Doki Y, Mori M, Mimori K.

Cancer Genomics Proteomics.   17 ( 2 )   141 - 149   2020.3

GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer. Reviewed International journal

111 ( 2 )   343 - 355   2020.2

Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer. Reviewed International journal

Masuda T, Noda M, Kogawa T, Kitagawa D, Hayashi N, Jomori T, Nakanishi Y, Nakayama KI, Ohno S, Mimori K.

Cancer Sci.   111 ( 3 )   924 - 931   2020.2

N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study. Reviewed International journal

Masuda T, Ueo H, Kai Y, Noda M, Hu Q, Sato K, Fujii A, Hayashi N, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Ohno S, Mimori K, Ueo H.

Int J Mol Sci.   21 ( 2 )   511   2020.1

ARL4C and Peritoneal Dissemination in Gastric Cancer. Reviewed International journal

Hu Q, Mimori K.

Ann Surg Oncol.   26 ( Suppl 3 )   547   2019.12

Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer. Reviewed International journal

Kouyama Y, Masuda T, Fujii A, Ogawa Y, Sato K, Tobo T, Wakiyama H, Yoshikawa Y, Noda M, Tsuruda Y, Kuroda Y, Eguchi H, Ishida F, Kudo SE, Mimori K.

Cancer Sci.   110 ( 10 )   3132 - 3144   2019.10

Distinct methylation levels of mature microRNAs in gastrointestinal cancers. Reviewed International journal

Konno M, Koseki J, Asai A, Yamagata A, Shimamura T, Motooka D, Okuzaki D, Kawamoto K, Mizushima T, Eguchi H, Takiguchi S, Satoh T, Mimori K, Ochiya T, Doki Y, Ofusa K, Mori M, Ishii H.

Nat Commun.   10 ( (1) )   3888   2019.8

Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer. Reviewed International journal

Sato K, Masuda T, Hu Q, Tobo T, Gillaspie S, Niida A, Thornton M, Kuroda Y, Eguchi H, Nakagawa T, Asano K, Mimori K.

EBioMedicine.   S2352-3964(19)30366-4.   2019.6

Preventive and promotive effects of habitual hot spa-bathing on the elderly in Japan. Reviewed International journal

Maeda T, Mimori K, Suzuki S, Horiuchi T, Makino N.

Sci Rep.   8 ( 1 )   133   2019.6

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens. Reviewed International journal

Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S,Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K,Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, NagaseT, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K,Aburatani H, Mano H.

Cancer Sci.   110 ( 4 )   1464 - 1479   2019.5

Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis. Reviewed International journal

Muto Y, Moroishi T, Ichihara K, Nishiyama M, Shimizu H, Eguchi H, Moriya K, Koike K, Mimori K, Mori M, Katayama Y, Nakayama KI.

Cancer Sci.   2019.5

Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents. Reviewed International journal

Yumimoto K, Sugiyama S, Mimori K, Nakayama KI.

Cancer Sci.   2019.5

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens. Reviewed International journal

Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H.

Cancer Sci.   110 ( 4 )   1464 - 1479   2019.4

A clinical trial of somatic and germline analyses for healthy longevity in a postoperative cancer patient. Reviewed International journal

Hayashi N, Kuroda Y, Saito T, Tsuruda Y, Niida A, Otsu H, Eguchi H, Masuda T, Suzuki Y, Natsugoe S, Mimori K.

Surg Today.   2019.3

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer. Reviewed International journal

Kurashige J, Yokobori T, Mima K, Sawada G, Takahashi Y, Ueo H, Takano Y, Matsumura T, Uchi R, Eguchi H, Sudo T, Sugimachi K, Mori M, Baba H, Mimori K.

Oncol Lett.   17 ( 2 )   2393 - 2399   2019.2

Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Reviewed International journal

Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S.

Nature.   565 ( 7739 )   312 - 317   2019.1

Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors. Reviewed International journal

Sato K, Niida A, Masuda T, Shimizu D, Tobo T, Kuroda Y, Eguchi H, Nakagawa T, Suzuki Y, Mimori K.

Cancer Genomics Proteomics.   16 ( 1 )   21 - 27   2019.1

CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis. Reviewed International journal

Shimizu D, Masuda T, Sato K, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Kodera Y, Mimori K.

Anticancer Res.   39 ( 1 )   99 - 106   2019.1

Preventive and promotive effects of habitual hot spa-bathing on the elderly in Japan Reviewed

Toyoki Maeda, Koshi Mimori, Sadao Suzuki, Takahiko Horiuchi, Naoki Makino

Scientific Reports   8 ( 1 )   2018.12

Cytolytic Activity (CYT) Score Is a Prognostic Biomarker Reflecting Host Immune Status in Hepatocellular Carcinoma (HCC). Reviewed International journal

Wakiyama H, Masuda T, Motomura Y, Hu Q, Tobo T, Eguchi H, Sakamoto K, Hirakawa M, Honda H, Mimori K.

Anticancer Res.   38 ( 12 )   6631 - 6638   2018.12

Prognostic Impact of Immune-Related Gene Expression in Preoperative Peripheral Blood from Gastric Cancer Patients. Reviewed International journal

Ito S, Fukagawa T, Noda M, Hu Q, Nambara S, Shimizu D, Kuroda Y, Eguchi H, Masuda T, Sato T, Katai H, Sasako M, Mimori K.

Ann Surg Oncol.   25 ( 12 )   3755 - 3763   2018.11

Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy. Reviewed International journal

Sugimachi K, Sakimura S, Kuramitsu S, Hirata H, Niida A, Iguchi T, Eguchi H, Masuda T, Morita M, Toh Y, Maehara Y, Suzuki Y, Mimori K.

Br J Cancer.   119 ( 4 )   419 - 423   2018.8

Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer. Reviewed International journal

Masuda T, Shinden Y, Noda M, Ueo H, Hu Q, Yoshikawa Y, Tsuruda Y, Kuroda Y, Ito S, Eguchi H, Ohno S, Mimori K.

Anticancer Res.   38 ( 8 )   4515 - 4523   2018.8

Cancer evolution and heterogeneity. Reviewed International journal

Mimori K, Saito T, Niida A, Miyano S.

Ann Gastroenterol Surg.   ２ ( ５ )   332 - 338   2018.7

Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric Cancer. Reviewed International journal

Shimizu D, Saito T, Ito S, Masuda T, Kurashige J, Kuroda Y, Eguchi H, Kodera Y, Mimori K.

Cancer Genomics Proteomics.   15 ( 4 )   313 - 320   2018.7

A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer. Reviewed International journal

Saito T, Niida A, Uchi R, Hirata H, Komatsu H, Sakimura S, Hayashi S, Nambara S, Kuroda Y, Ito S, Eguchi H, Masuda T, Sugimachi K, Tobo T, Nishida H, Daa T, Chiba K, Shiraishi Y, Yoshizato T, Kodama M, Okimoto T, Mizukami K, Ogawa R, Okamoto K, Shuto M, Fukuda K, Matsui Y, Shimamura T, Hasegawa T, Doki Y, Nagayama S, Yamada K, Kato M, Shibata T, Mori M, Aburatani H, Murakami K, Suzuki Y, Ogawa S, Miyano S, Mimori K.

Nat Commun.   9 ( 1 )   2884   2018.7

GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12. Reviewed International journal

Tanikawa C, Kamatani Y, Takahashi A, Momozawa Y, Leveque K, Nagayama S, Mimori K, Mori M, Ishii H, Inazawa J, Yasuda J, Tsuboi A, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Wakai K, Koyama T, Takezaki T, Yuji K, Murakami Y, Nakamura Y, Kubo M, Matsuda K.

Carcinogenesis.   39 ( 5 )   652 - 660   2018.5

Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling Reviewed

Atsushi Niida, Satoshi Nagayama, Satoru Miyano, Koshi Mimori

Cancer Science   109 ( 4 )   884 - 892   2018.4

Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling. Reviewed International journal

Niida A, Nagayama S, Miyano S, Mimori K.

Cancer Sci.   109 ( 4 )   884 - 892   2018.4

Combined mutation of Apc, Kras, and Tgfbr2 effectively drives metastasis of intestinal cancer Reviewed

Eri Sakai, Mizuho Nakayama, Hiroko Oshima, Yuta Kouyama, Atsushi Niida, Satoshi Fujii, Atsushi Ochiai, Keiichi Nakayama, Koshi Mimori, Yutaka Suzuki, Chang Pyo Hong, Chan Young Ock, Seong Jin Kim, Masanobu Oshima

Cancer Research   78 ( 5 )   1334 - 1346   2018.3

Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer Reviewed

Qingjiang Hu, Takaaki Masuda, Kuniaki Sato, Taro Tobo, Sho Nambara, Shinya Kidogami, Naoki Hayashi, Yohsuke Kuroda, Shuhei Ito, Hidetoshi Eguchi, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Koshi Mimori

Annals of Surgical Oncology   25 ( 3 )   745 - 753   2018.3

PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer Reviewed

Yuki Kiyozumi, Masaaki Iwatsuki, Junji Kurashige, Yoko Ogata, Kohei Yamashita, Yuki Koga, Tasuku Toihata, Yukiharu Hiyoshi, Takatsugu Ishimoto, Yoshifumi Baba, Yuji Miyamoto, Naoya Yoshida, Kazuyoshi Yanagihara, Koshi Mimori, Hideo Baba

International Journal of Cancer   2018.1

Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients. Reviewed International journal

Shinden Y, Sugimachi K, Tanaka F, Fujiyoshi K, Kijima Y, Natsugoe S, Mimori K.

Mol Clin Oncol.   8 ( 1 )   93 - 98   2018.1

Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma. Reviewed International journal

Iguchi T, Ueda M, Masuda T, Nambara S, Kidogami S, Komatsu H, Sato K, Tobo T, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.

Oncology.   5 ( 3 )   179 - 187   2018.1

Long-term outcome of adipose-derived regenerative cell-enriched autologous fat transplantation for reconstruction after breast-conserving surgery for Japanese women with breast cancer Reviewed

Shuhei Ito, Yuichiro Kai, Takaaki Masuda, Fumiaki Tanaka, Toshifumi Matsumoto, Yukio Kamohara, Hiroshi Hayakawa, Hiroaki Ueo, Hideki Iwaguro, Marc H. Hedrick, Koshi Mimori, Masaki Mori

Surgery Today   47 ( 12 )   1500 - 1511   2017.12

Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma Reviewed

Tomoya Sudo, Ryosuke Nishida, Akihiko Kawahara, Kouhei Saisho, Koshi Mimori, Akira Yamada, Atsuhi Mizoguchi, Kazutaka Kadoya, Satoru Matono, Naoki Mori, Toshiaki Tanaka, Yoshito Akagi

Annals of Surgical Oncology   24 ( 12 )   3763 - 3770   2017.11

Japanese genome-wide association study identifies a significant colorectal cancer susceptibility locus at chromosome 10p14 Reviewed

Yusuke Takahashi, Keishi Sugimachi, Ken Yamamoto, Atsushi Niida, Teppei Shimamura, Tetsuya Sato, Masahiko Watanabe, Junichi Tanaka, Shinei Kudo, Kenichi Sugihara, Kazuo Hase, Masato Kusunoki, Kazutaka Yamada, Yasuhiro Shimada, Yoshihiro Moriya, Yutaka Suzuki, Satoru Miyano, Masaki Mori, Koshi Mimori

Cancer Science   108 ( 11 )   2239 - 2247   2017.11

Diagnostic laparoscopy for pneumatosis intestinalis in a very elderly patient A case report Reviewed

Shuhei Ito, Takaaki Masuda, Noboru Harada, Ayumi Matsuyama, Motoharu Hamatake, Takashi Maeda, Shinichi Tsutsui, Hiroyuki Matsuda, Koshi Mimori, Teruyoshi Ishida

Annals of Medicine and Surgery   21   109 - 113   2017.9

MicroRNAs as biomarkers in colorectal cancer Reviewed

Takaaki Masuda, Naoki Hayashi, Yohsuke Kuroda, Shuhei Ito, Hidetoshi Eguchi, Koshi Mimori

Cancers   9 ( 9 )   2017.9

Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma Reviewed

Keishi Sugimachi, Miki Nishio, Shinichi Aishima, Yohsuke Kuroda, Tomohiro Iguchi, Hisateru Komatsu, Hidenari Hirata, Shotaro Sakimura, Hidetoshi Eguchi, Yuki Bekki, Kenji Takenaka, Yoshihiko Maehara, Akira Suzuki, Koshi Mimori

Oncology   93 ( 1 )   67 - 74   2017.7

Overexpression of CXCR7 Is a novel prognostic indicator in gastric cancer Reviewed

Sho Nambara, Tomohiro Iguchi, Eiji Oki, Patrick Tan, Yoshihiko Maehara, Koshi Mimori

Digestive Surgery   34 ( 4 )   312 - 318   2017.7

MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation Reviewed

Kohei Otsubo, H. Goto, M. Nishio, K. Kawamura, S. Yanagi, W. Nishie, T. Sasaki, T. Maehama, H. Nishina, Koshi Mimori, T. Nakano, H. Shimizu, T. W. Mak, K. Nakao, Yoichi Nakanishi, A. Suzuki

Oncogene   36 ( 29 )   4201 - 4211   2017.7

Extraction of cell-free DNA from urine, using polylysine-coated silica particles Reviewed

Sho Takano, Qingjiang Hu, Takaki Amamoto, Paulo Refinetti, Koshi Mimori, Takashi Funatsu, Masaru Kato

Fresenius Zeitschrift fur Analytische Chemie   409 ( 16 )   4021 - 4025   2017.6

DDR2 expression is associated with a high frequency of peritoneal dissemination and poor prognosis in colorectal cancer Reviewed

Shin Sasaki, Masami Ueda, Tomohiro Iguchi, Manabu Kaneko, Hiroshi Nakayama, Toshiyuki Watanabe, Atsuhiko Sakamoto, Koshi Mimori

Anticancer Research   37 ( 5 )   2587 - 2591   2017.5

phyC Clustering cancer evolutionary trees Reviewed

Yusuke Matsui, Atsushi Niida, Ryutaro Uchi, Koshi Mimori, Satoru Miyano, Teppei Shimamura

PLoS Computational Biology   13 ( 5 )   2017.5

Up-regulation of SLC9A9 promotes cancer progression and is involved in poor prognosis in colorectal cancer Reviewed

Masami Ueda, Tomohiro Iguchi, Takaaki Masuda, Hisateru Komatsu, Sho Nambara, Shotaro Sakimura, Hidenari Hirata, Ryutaro Uchi, Hidetoshi Eguchi, Shuhei Ito, Keishi Sugimachi, Tsunekazu Mizushima, Yuichiro Doki, Masaki Mori, Koshi Mimori

Anticancer Research   37 ( 5 )   2255 - 2263   2017.5

Phosphoserine phosphatase is a novel prognostic biomarker on chromosome 7 in colorectal cancer Reviewed

Kuniaki Sato, Takaaki Masuda, Qingjiang Hu, Taro Tobo, Shinya Kidogami, Yushi Ogawa, Tomoko Saito, Sho Nambara, Hisateru Komatsu, Hidenari Hirata, Shotaro Sakimura, Ryutaro Uchi, Naoki Hayashi, Tomohiro Iguchi, Hidetoshi Eguchi, Shuhei Ito, Takashi Nakagawa, Koshi Mimori

Anticancer Research   37 ( 5 )   2365 - 2371   2017.5

MicroRNA in various aspects of cancer development Reviewed

Sho Nambara, Koshi Mimori

Japanese Journal of Cancer and Chemotherapy   44 ( 5 )   362 - 366   2017.5

Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma. Reviewed International journal

Ann Surg Oncol.   ２４ ( ３ )   850 - 859   2017.3

Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma Reviewed

Hisateru Komatsu, Tomohiro Iguchi, Takaaki Masuda, Hidenari Hirata, Masami Ueda, Shinya Kidogami, Yushi Ogawa, Kuniaki Sato, Qingjiang Hu, Sho Nambara, Tomoko Saito, Shotaro Sakimura, Ryutaro Uchi, Shuhei Ito, Hidetoshi Eguchi, Keishi Sugimachi, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori, Koshi Mimori

Annals of Surgical Oncology   24 ( 3 )   850 - 859   2017.3

Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma. Reviewed International journal

Anticancer Res.   37 ( 3 )   1083 - 1090   2017.3

Overexpression of CXCR7 Is a Novel Prognostic Indicator in Gastric Cancer. Reviewed International journal

Dig Surg   2016.12

miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis. Reviewed International journal

PLoS One   １１ ( １１ )   e0165912 - e0165912   2016.11

Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence. Reviewed International journal

Oncotarget   7 ( 38 )   62280 - 62291   2016.9

8q24 Polymorphisms and Diabetes Mellitus Regulate Apolipoprotein A-IV in Colorectal Carcinogenesis Reviewed International journal

Ann Surg Oncol.   ２３ ( ４ )   546- - 551   2016.8

Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma. Reviewed International journal

Anticancer Res.   36 ( ５ )   2139 - ２１４４   2016.6

Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green Reviewed International journal

９ ( ６ )   27525 - 27525   2016.6

HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma. Reviewed International journal

Anticancer Res.   36 ( 6 )   2767 - 2773   2016.6

Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer. Invited Reviewed International journal

Ann Surg Oncol   23 ( 12 )   3948 - 3955   2016.6

Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma. Reviewed International journal

Cancer Res   76 ( 11 )   3265 - 3276   2016.6

Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma. Reviewed International journal

Hisateru Komatsu, Iguchi Tomohiro, Masami Ueda, Sho Nanbara, Tomoko Saito, Hidenari Hirata, Shotaro Sakimura, Yuki Takano, Ryutaro Uchi, Shinden Yoshiaki, Hidetoshi Eguchi, Takaaki Masuda, Keishi Sugimachi, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori, Koshi Mimori

Oncol Rep   35 ( 4 )   2073 - 2080   2016.4

An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma. Reviewed International journal

Genta Sawada, Atsushi Niida, HIdenari Hirata, Hisateru Komatsu, Ryutaro Uchi, Teppei Shimamura, Yusuke Takahashi, Junji Kurashige, Tae Matsumura, Hiroki Ueo, Yuki Takano, Masami Ueda, Shotaro Sakimura, Shinden Yoshiaki, Hidetoshi Eguchi, Sudo Tomoya, Keishi Sugimachi, Koshi Mimori

PLoS One.   10 ( 10 )   e0139808   2015.10

Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients. Reviewed International journal

Keishi Sugimachi, Shotaro Sakimura, Akira Tomokuni, Ryutaro Uchi, Hidenari Hirata, Hisateru Komatsu, Shinden Yoshiaki, Iguchi Tomohiro, Hidetoshi Eguchi, Takaaki Masuda, Kazutoyo Morita, Ken Shirabe, Hidetoshi Eguchi, Yoshihiko Maehara, Masaki Mori, Koshi Mimori

J Clin Med.   4 ( 8 )   1600 - 1611   2015.8

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Reviewed International journal

Tae Matsumura, Keishi Sugimachi, Hisae Iinuma, Yusuke Takahashi, Junji Kurashige, Genta Sawada, Masami Ueda, Ryutaro Uchi, Hiroki Ueda, Yuki Takano, Shinden Yoshiaki, Hidetoshi Eguchi, Hirofumi Yamamoto, Yuichiro Doki, Takahiro Ochiya, Koshi Mimori

Br J Cancer   113 ( 2 )   275 - 281   2015.7

miR-29b is an indicator of prognosis in breast cancer patients. Reviewed International journal

Shinden Yoshiaki, Iguchi Tomohiro, Akiyoshi Sayuri, Hiroki Ueo, Masami Ueda, Hidenari Hirata, Shotaro Sakimura, Ryutaro Uchi, Yuki Takano, Hidetoshi Eguchi, Keishi Sugimachi, Yuko Kijima, Shoji Natsugoe, Koshi Mimori

Mol Clin Oncol.   3 ( 4 )   919 - 923   2015.7

Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer. Reviewed International journal

Masami Ueda, Iguchi Tomohiro, Sho Nanbara, Tomoko Saito, Hisateru Komatsu, Shotaro Sakimura, Hidenari Hirata, Ryutaro Uchi, Yuki Takano, Shinden Yoshiaki, Hidetoshi Eguchi, Takaaki Masuda, Keishi Sugimachi, Hirofumi Yamamoto, Yuichiro Doki, Koshi Mimori

Ann Surg Oncol.   3   S1490. - S1498   2015.6

Rapid intraoperative visualization of breast lesions with γ-glutamyl hydroxymethyl rhodamine green. Invited Reviewed International journal

13 ( 5 )   12080   2015.6

A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Reviewed International journal

Iguchi Tomohiro, Ryutaro Uchi, Sho Nanbara, Tomoko Saito, Hisateru Komatsu, Hidenatri Hitara, Masami Ueda, Shotaro Sakimura, Yuki Takano, Junji Kurashige, Shinden Yoshiaki, Hidetoshi Eguchi, Keishi Sugimachi, Yoshihiko Maehara, Koshi Mimori

Anticancer Res.   ３５ ( 3 )   １３８５ - １３８８   2015.5

A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Reviewed International journal

2015.5

Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer. Reviewed International journal

Hidekazu Takahashi, Junichi Nishimura, Yoshinori Kagawa, Yoshihiro Kano, Yusuke Takahashi, Xin Wu, Masayuki Hiraki, Atsushi Hamabe, Masamitsu Konno, Naotsugu Haraguchi, Ichiro Takemasa, Tsunekazu Mizushima, Masaru Ishii, Koshi Mimori, Hideshi Ishii, Yuichiro Doki, Masaki Mori, Hirofumi Yamamoto

Molecular Cancer Therapeutics   2015.4

F-box protein FBXW7 inhibits-cancer metastasis in a non-cell-autonomous manner Reviewed International journal

JOURNAL OF CLINICAL INVESTIGATION   125 ( 2 )   2015.2

The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer. Reviewed International journal

Shotaro Sakimura, Keishi Sugimachi, Junji Kurashige, Msasami Ueda, Hidenari Hirata, Sho Nanbara, Hisateru Komatsu, Tomoko Saito, Yuki Takano, Ryutaro Uchi, Etsuko Sakimura, Shinden Yoshiaki, Iguchi Tomohiro, Hidetoshi Eguchi, Yugo Oba, Sumio Hoka, Koshi Mimori

Ann Surg Oncol.   2015.2

Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer Reviewed International journal

Junji Kurasige, Koshuke Mima, Genta Sawada, Yusuke Takahashi, Hidetoshi Eguchi, Keishi Sugimachi, Masaki Mori, Kazuyoshi Yanagihara, Masakazu Yashiro, Kosei Hirakawa, Hideo Baba, Koshi Mimori

CARCINOGENESIS   36 ( 1 )   133 - 141   2015.1

Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer. Reviewed International journal

Masami Ueda, Iguchi Tomohiro, Sho Nanbara, Tomoko Saito, Hisateru Komatsu, Shotaro Sakimura, Hidenari Hirata, Ryutaro Uchi, Yuki Takano, Shinden Yoshiaki, Hidetoshi Eguchi, Takaaki Masuda, Keishi Sugimachi, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori, Koshi Mimori

Ann Surg Oncol.   2015.1

Diminished Expression of MiR-15a Is an Independent Prognostic Marker for Breast Cancer Cases Reviewed International journal

Shinden Yoshiaki, Akiyoshi Sayuri, Ueo Hiroki, Sho Nanbara, Tomoko Saito, Hisateru Komatsu, Masami Ueda, Hidenari Hirata, Shotaro Sakimura, Ryutaro Uchi, Yuki Takano, Iguchi Tomohiro, Hidetoshi Eguchi, Keishi Sugimachi, Y Kijima, Hiroaki Ueo, Shoji Natsugoe, Koshi Mimori

ANTICANCER RESEARCH   35 ( 1 )   2015.1

Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer Reviewed International journal

Junji Kurasige, Koshuke Mima, Genta Sawada, Yusuke Takahashi, Hidetoshi Eguchi, Keishi Sugimachi, Masaki Mori, Kazuyoshi Yanagihara, Masakazu Yashiro, Kosei Hirakawa, Hideo Baba, Koshi Mimori

CARCINOGENESIS   36 ( 1 )   133 - 141   2015.1

Loss of CDCP1 Expression Promotes Invasiveness and Poor Prognosis in Esophageal Squamous Cell Carcinoma Reviewed International journal

Genta Sawada, Yusuke Takahashi, Atsushi Niida, Teppei Shimamura, Junji Kurashige, Tae Matsumura, Hiroki Ueo, Ryutaro Uchi, Yuki Takano, Masami Ueda, Hidernari Hirata, Shotaro Sakimura, Shinden Yoshiaki, Hidetoshi Eguchi, Sudo Tomoya, Keishi Sugimachi, Satoru Miyano, Yuichiro Doki, Masaki Mori, Koshi Mimori

ANNALS OF SURGICAL ONCOLOGY   21   2014.12

Clinical Significance of GAB2, a Scaffolding/Docking Protein Acting Downstream of EGFR in Human Colorectal Cancer Reviewed International journal

Tae Matsumura, Keishi Sugimachi, Yusuke Takahashi, Ryutaro Uchi, Genta Sawada, Masami Ueda, Hidenari Hirata, Shotaro Sakimura, Hiroki Ueo, Yuki Takano, Junji Kurashige, Shinden Yoshiaki, Hidetoshi Eguchi, Sudo Tomoya, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori, Koshi Mimori

ANNALS OF SURGICAL ONCOLOGY   21   S743 - S749   2014.12

Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma. Reviewed International journal

Hidenari Hirata, Keishi Sugimachi, Yusuke Takahashi, Masami Ueda, Shotaro Sakimura, Ryutaro Uchi, Junji Kurashige, Yuki Takano, Sho Nanbara, Hisateru Komatsu, Tomoko Saito, Shinden Yoshiaki, Iguchi Tomohiro, Hidetoshi Eguchi, Kazushige Atsumi, Katsumi Sakamoto, Toshio Doi, Masakazu Hirakawa, Hiroshi Honda, Koshi Mimori

Ann Surg Oncol.   2014.11

Prognostic Significance of High Mobility Group Box 1 (HMGB1) Expression in Patients with Colorectal Cancer Reviewed International journal

Masami Ueda, Yusuke Takahashi, Shinden Yoshiaki, Shotaro Sakimura, Hidenari Hirata, Ryutaro Uchi, Yuki Takano, Junji Kurashige, Iguchi Tomohiro, Hidetoshi Eguchi, Keishi Sugimachi, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori, Koshi Mimori

ANTICANCER RESEARCH   34 ( 10 )   5357 - 5362   2014.10

Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition Reviewed International journal

Atsushi Hamabe, Masamitsu Konno, Nobuhiro Tanuma, Hiroshi Shima, Kenta Tsunekuni, Koichi Kawamoto, Naohiro Nishida, Jun Koseki, Koshi Mimori, Noriko Gotoh, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori, Hideshi Ishii

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   111 ( 43 )   2014.10

A single nucleotide polymorphism in fibronectin 1 determines tumor shape in colorectal cancer. Reviewed International journal

Hiroyuki Kida, Yuki Takano, Ken Yamamoto, Masaki Mori, Katsuhiko Yanaga, Jun-Ichi Tanaka, Shin-Ei Kudo, Koshi Mimori

Oncol Rep.   32 ( 2 )   548 - 552   2014.8

Aberrant Expression of Plastin-3 Via Copy Number Gain Induces the Epithelial-Mesenchymal Transition in Circulating Colorectal Cancer Cells.

Koshi Mimori

ANNALS OF SURGICAL ONCOLOGY   2014.1

Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer

Koshi Mimori

ANNALS OF SURGICAL ONCOLOGY   21 ( 1 )   2014.1

Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. International journal

Koshi Mimori

Br J Cancer. 2014 Jan 7;110(1):164-71. doi: 10.1038/bjc.2013.698. Epub 2013 Nov 5.   2014.1

Contrasting Expression Patterns of Histone mRNA and microRNA 760 in Patients with Gastric Cancer

Koshi Mimori

CLINICAL CANCER RESEARCH   19 ( 23 )   2013.12

Cell Cycle-Dependent Rho GTPase Activity Dynamically Regulates Cancer Cell Motility and Invasion In Vivo

Koshi Mimori

PLOS ONE   8 ( 12 )   2013.12

PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression

Koshi Mimori

BRITISH JOURNAL OF CANCER   109 ( 8 )   2013.10

EGFR gets in the way of microRNA biogenesis

Koshi Mimori

CELL RESEARCH   23 ( 10 )   2013.10

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

Koshi Mimori

GENOME RESEARCH   23 ( 9 )   2013.9

Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway

Iwaya Takeshi, Yokobori Takehiko, Nishida, Naohiro, Sudo Tomoya, Fumiaki Tanaka, Shibata Kohei, Sawada, Genta, Takahashi, Yusuke, Ishibashi, Masahisa, Wakabayashi, Go, Mori, Masaki, Koshi Mimori

CARCINOGENESIS   33 ( 12 )   2391 - 2397   2012.12

MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells

Nishida, Naohiro, Yamashita, Shinya, Koshi Mimori, Sudo Tomoya, Fumiaki Tanaka, Shibata Kohei, Yamamoto, Hirofumi, Ishii, Hideshi, Doki, Yuichiro, Mori, Masaki

ANNALS OF SURGICAL ONCOLOGY   19 ( 9 )   3065 - 3071   2012.9

Increased Risk for CRC in Diabetic Patients with the Nonrisk Allele of SNPs at 8q24

Ishimaru, Shinya, Koshi Mimori, Ken Yamamoto, Hiroshi Inoue, Imoto, Seiya, Shuichi; Yamaguchi, Rui; Sato, Sato Tetsuya, Toh, Hiroyuki, Iinuma, Hisae, Toyoki Maeda, Ishii, Hideshi, Suzuki, Sadao, Tokudome, Shinkan, Watanabe, Masahiko, Tanaka, Jun-ichi, Kudo, Shin-ei, Sugihara, Ken-ichi, Hase, Kazuo, Mochizuki, Hidetaka

ANNALS OF SURGICAL ONCOLOGY   19 ( 9 )   2853 - 2858   2012.9

Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma

Yokobori, Takehiko, Koshi Mimori, Iwatsuki, Masaaki, Ishii, Hideshi, Fumiaki Tanaka, Sato Tetsuya, Toh, Hiroyuki, Sudo Tomoya, Iwaya, Takeshi, Tanaka, Yoichi, Onoyama, Ichiro, Kuwano, Hiroyuki, Nakayama, Keiichi I., Mori, Masaki

INTERNATIONAL JOURNAL OF ONCOLOGY   41 ( 1 )   253 - 259   2012.7

Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters. Reviewed International journal

Nishida N, Nagahara M, Sato T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Sugihara K, Doki Y, Mori M.

Clin Cancer Res   18 ( 11 )   2012.6

Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Reviewed International journal

Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M.

Cancer Res   71 ( 20 )   2011.8

Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Reviewed International journal

Miyoshi N, Ishii H, Nagano H, Haraguchi, Dewi DL, Kano Y Nishikawa S, Tanemura T, Mimori K, Tanaka F, Saito T, Nishimura J; Takemasa I, Mizusima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M.

Cell Stem Cell   2011.5

Clinical Significance of Circulating Tumor Cells Including Cancer Stem-like Cells in Peripheral Blood for Recurrence and Prognosis in Colorectal Cancer Patients with Dukes stage B and C. Invited Reviewed International journal

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M.

J Clin Oncol   29   2011.5

Reply to B Faltas et al. Reviewed International journal

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Nozawa K, Ishihara Matsuda KN, Fukushima R, Okinaga K, Sasako M, Mori M

J Clin Oncol   2011.5

Clinical significance of miR-146a in gastric cancer cases. Reviewed International journal

Kogo R , Mimori K, Tanaka F, Komune S, Mori M

Clin Cancer Res   2011.5

Clinical significance of miR-146a in gastric cancer cases. Reviewed International journal

Kogo R , Mimori K, Tanaka F, Komune S, Mori M

Clin Cancer Res   2011.5

Serum Matrix-Metalloproteinase-1 is a Bona Fide Prognostic Marker for Colorectal Cancer. Reviewed International journal

Mimori K*, Tahara K*, Iinuma H, Iwatsuki M, Yokobori T, Ishii H, Anai H, Kitano S,Mori M

Ann Surg Oncol   17 ( 12 )   2011.5

Regulation of the MDM2-p53 Pathway and Tumor Growth by PICT1/GLTSCR2 via Nucleolar RPL11. Reviewed International journal

Sasaki M, Kawahara K, Nishio M, Mimori K, Kogo R, Hamada K, Itoh B, Wangjia J, Komatsu Y, Yang YR, Hikasa H, Horie Y, Yamashita T, Kamijo T, Zhang Y, Prives C, Nakano T, Mak TW, Sasaki T, Maehama T, Mori M, Suzuki A.

Nat Med   2011.4

Identification of Recurrence-Related microRNAs in the Bone Marrow of Breast Cancer Patients. Reviewed International journal

Mimori K*, Ota D*, Yokobori T, Iwatsuki M, Kataoka A, Masuda N, Ishii H, Ohno S,Mori S

Int J Oncol   2010.5

Preoperative u-PAR Gene Expression in Bone Marrow Indicates the Potential Power of Recurrence in Breast Cancer Cases. International journal

Mimori K, Kataoka A, Yamaguchi H, Masuda N, Kosaka Y, Ishii H, Ohno S, Mori M.

Ann Surg Oncol   2009.5

Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.

Mimori K, Ishii H, Inoue H, Barnard GF, Mori M.

J Gastroenterol Hepatorol   2009.5

Important matters to identify robust markers for metastasis and recurrence in solid cancer.

Mimori K, Iwatsuki M, Yokobori T, Mori M.

Ann Surg Oncol   2009.5

Hematogenous Metastasis in Gastric Cancer Requires Isolated Tumor Cells and Expression of Vascular Endothelial Growth Factor Receptor-1

Mimori K, Fukagawa T Kosaka Y, Kita Y, Ishikawa K, Etoh T, Iinuma H, Sasako M, Mori M

Clin Cancer Res   2008.6

Loss of MAL expression in precancerous lesions of the esophagus.

Mimori K, Nishida K Nakamura Y, Ieta K, Yoshikawa Y, Sasaki A, Ishii H, Alonso MA, Mori M

Ann Surg Oncol   2007.1

Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.

Nagahara H, Mimori K, Ohta M, Utsunomiya T, Inoue H, Barnard GF, Ohira M, Hirakawa K, Mori M.

Clin Cancer Res   11 ( 4 )   1368 - 1371   2005.1

FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.

Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, MoriM

Cancer Res   66 ( 5 )   2683 - 2690   2005.1

FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.

Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, MoriM

Cancer Res   66 ( 5 )   2683 - 2690   2005.1

Coexpression of MMP-7 and EGF receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells

Mimori K

Clin Cancer Res   10 ( 24 )   8243 - 8249   2004.12

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway

Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M.

Oncogene   22 ( 22 )   3463 - 3471   2003.1

A polymorphic change at codon 299 and splicing isoforms of SMARB1 gene in human solid carcinomas.

Mimori K, Inoue H, Ueo H, Tanaka Y, Mori M

Genomics   2002.1

Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma.

Mimori K*, Mori M*, Masuda T, Yoshinaga K, Yamashita K, Matsuyama A, Inoue H. (*equal contribution)

Cancer Res   61 ( 20 )   7379 - 7382   2001.3

Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit.

Shiraishi T, Druck T, Mimori K, Flomenberg J, Berk L, Alder H, Miller W, Huebner K, Croce CM

Proc Natl Acad Sci U S A.   2001.2

Effect of adenoviral trancduction of FHIT into esophageal cancer cells.

Ishii H, Dumon K, Vacchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM.

Cancer Res   2001.1

Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.

Mori M,Mimori K, Shiraishi T, Alder H, Inoue H, Tanaka Y, Sugimachi K, Huebner K, Croce CM.

Cancer Res   60 ( 5 )   1177 - 1182   2000.1

Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.

Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K, Akiyoshi T

J Clin Oncol   16 ( 1 )   128 - 132   1997.1

p27 expression and gastric carcinoma. Reviewed

Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T.

Nat Med   3 ( 6 )   593 - 593   1997.1

Elongation factor 1 gamma mRNA expression in oesophageal carcinoma. International journal

Mimori K, Mori M, Inoue H, Ueo H, Mafune K, Akiyoshi T and Sugimachi K

Gut   38 ( 1 )   66 - 70   1996.10

Elongation factor 1gamma mRNA expression in oesophageal carcinoma

Mimori K, Mori M, Inoue H, Mafune K, Tanaka Y, Takubo T, Ueo H, Akiyoshi T, Sugimachi K.

Gut   1996.1

Detection of cancer micrometastasis in lymph nodes by the reverse transcriptase-polymerase chain reaction.

Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H, Akiyoshi T.

Cancer Res   55 ( 15 )   3417 - 3420   1995.11

Identification of Bona-fide Characteristics of Esophageal Cancer by Adenoviral-FHIT Treatment International conference

Mimori K, Ishii H, Okamoto M, Barnard GF, Huebner K, Croce CM and Mori M

58th Society of Surgical Oncology  2005.3 

Loss of MAL Expression in Precancerous (Dysplastic) Lesion of the Esophagus International conference

Mimori K, Nishida K, Ieta K, Nakamura Y, Tanaka F, Sasaki A, Inoue H, Alonso MA and Mori M.

59th Society of Surgical Oncology  2006.3 

わが国における遠隔手術の将来について Invited

三森功士

第88回日本温泉気候物理医学会  2023.5 

実装化される未来のがん治療 Invited

三森功士

令和４年度別府市医師会学術集会  2023.3 

がんの進化に関する基礎研究 Invited

三森功士

文科省「富岳」成果創出加速プログラム  2022.12 

進行食道がんに対する化学放射線治療後に生じた再発への進化機構の解明. Invited

三森功士

第35回日本バイオセラピィ学会  2022.12 

MSI-H 大腸がんにおける免疫逃避能獲得にむけたゲノム進化機構の解明. Invited

三森功士

第68回日本病理学会秋期特別総会  2022.11 

Survivor Scientist Program Invited

2022.10 

多領域シークエンスと進化シミュレーションによるがん腫瘍内ダイバーシティの解明：大腸がんを例として Invited

三森功士

関東骨軟部腫瘍の基礎を語る会  2022.9 

大腸がん薬物療法について Invited

三森功士

横浜癌診療webセミナー  2022.7 

鶴尾隆賞受賞講演 Invited

三森功士

第26回がん分子標的治療学会  2023.6 

Microsatellite instability-high CRC acquires frequent sub-clonal immune escape mechanisms by Darwinian evolution. Invited International conference

2022.6 

cfDNAパネルと腫瘍遺伝子パネルとの適切な役割分担とは？

三森功士

第19回日本臨床腫瘍学会学術集会  2022.2 

大腸がんゲノム進化とがん微小環境について

三森功士

第19回日本臨床腫瘍学会学術集会  2022.2 

大腸がんの進化と選択圧となるがん微小環境について Invited

三森　功士

第33回早期大腸癌研究会  2021.11 

A Basic Traits of ctDNA To Be Applied for the Early Diagnosis of Recurrence in CRC cases Invited International conference

Koshi Mimori

2020.10 

消化器がん進化の解明〜リキッドバイオプシーの研究の最前線〜 Invited

三森功士

大阪大学消化器外科研究会  2020.10 

An overview of liquid biopsy and basic traits of ctDNA & Opinions: Liquid biopsy in the future

2020.10 

術後再発大腸がん患者においてctDNA変異検出と腫瘍免疫応答について

三森功士、長山聡、増田隆明

第4回Liquid Biopsy研究会  2020.1 

食道癌ＣＲＴ耐性がんにおけるクローン進化の特徴

三森功士、平田秀成、増田隆明

第42回日本分子生物学会  2019.12 

Comprehensive analysis of the cancer evolution from primary to recurrence in sporadic CRC cases Invited International conference

Koshi Mimori

TEMTIA-IX(the 9th EMT International Association Meeting)  2019.11 

難治性を示す 消化器がんのクローン進化の特徴 Invited

三森功士

国立がん研究センター研究所セミナー  2019.5 

消化器がんにおける様々な進化機構について〜新たな大腸がん進化機構の解明〜 Invited

三森功士

第44回北里大学医学会総会  2018.11 

食道がん放射線化学療法にみる治療ドリヴンの進化機構について

三森功士

第29回日本消化器癌発生学会  2018.11 

大腸発がんから進行がんとなり難治性を呈するまでの新たな大腸がんモデル

三森功士

公益財団法人高松宮妃癌研究基金 第49回国際シンポジウム  2018.11 

術後再発大腸がん患者においてctDNA変異検出ト腫瘍免疫応答について

三森功士

第27回日本がん転移学会学術集会・総会  2018.7 

がん進化論からみた腫瘍免疫療法の有効性についての考察 Invited

三森功士

第73回日本消化器外科学会総会  2018.7 

がんゲノム進化の解明と臨床応用にむけてのアプローチ Invited

三森功士

第117回北海道癌談話会　春期シンポジウム  2018.5 

Evolution of Colorectal Cancer via Genomic Alterations Hampering the Tumor Immune Respones. Invited International conference

Koshi Mimori

The 33rd Nagoya International Cancer Treatment Symposium  2018.2 

大腸がんにおける新たな進化と多様性創出機構について Invited

三森功士

2017.12 

大腸の発がんと進展における「進化のシフト」について

三森功士

金沢大学がん進展制御研究所　 共同利用・共同研究拠点シンポジウム  2017.10 

消化器がん転移再発診断と治療評価法に関するctDNA解析の臨床的有用性と今後の課題

三森功士

第55回日本癌治療学会学術集会  2017.10 

食道がんゲノム情報に基づく診断と治療戦略の構築

三森功士

2017.10 

大腸発がんから進行がんにいたる過程のゲノムレベル進化について

三森功士

第3回がんゲノム・エピゲノムセミナー  2017.10 

消化器がん症例の様々な臨床的局面における血中ctDNA突然変異検出の意義

三森功士

第26回日本がん転移学会  2017.7 

消化器癌におけるctDNA検出の臨床的意義と臨床応用にむけての提言

三森功士

第72回日本消化器外科学会  2017.7 

プロパゲルマニウム（SK-818）の骨髄由来細胞制御機構による癌転移巣増殖制御について Invited

三森　功士

第38回日本炎症・再生医学会  2017.7 

大腸がんの進化と転移再発を決める選択圧について Invited

三森　功士

昭和大学横浜北部病院 2017年消化器センター軽井沢セミナー  2017.6 

がん治療における革新的変化を踏まえた最先端技術，新たな開発戦略の現状と今後の方向性

三森功士

第23回抗悪性腫瘍薬開発フォーラム  2017.6 

大腸がんのゲノム解析による新たな発がん・がん進展モデルの提唱

三森 功士

第26回泌尿器科分子・細胞研究会  2017.3 

大腸がんのゲノム・エピゲノムレベルの進化と多様性の解明 Invited

三森 功士

エピジェネティック療法研究会  2017.2 

日本人食道癌致死率逓減のための分子遺伝学的特徴と超早期診断の実現

三森 功士

第35回日本口腔腫瘍学会  2017.1 

大腸癌のゲノム進化にみる自然選択説と中立進化説〜固形がん原発巣の一腫瘍内多様性について〜 Invited

三森 功士

九州胆・膵癌治療フォーラム  2017.1 

大腸がんにおける多様性創出機構の解明 Invited

三森 功士

金沢大学がん進展制御研究所セミナー  2016.11 

大腸がん原発巣の進化において多様性を生じるストレス・選択圧について Invited

三森 功士

第11回臨床ストレス応答学会  2016.11 

マイクロRNAを活用した近未来がん診療

三森 功士

第14回日本臨床腫瘍学会  2016.7 

がん幹細胞および幹細胞ニッチを制御する分子標的治療の確立を目指して Invited

三森 功士

第14回日本臨床腫瘍学会  2016.7 

乳がん根治術後の転移再発予防への挑戦〜がん転移ニッチの増殖制御をめざして〜

三森 功士

第25回日本がん転移学会学術集会  2016.7 

Proposal of new tactics to overcome resistance to molecular target therapy provoked heterogenetiy.

2016.7 

Proposal of new tactics to overcome resistance to molecular target therapy provoked heterogenetiy.

2016.7 

大腸癌原発巣から転移巣へのゲノム・エピレベルの進化

三森 功士, 新井田　厚司, 内　龍太郎, 高橋　佑典, 森　正樹, 宮野　悟

第24回日本がん転移学会学術集会  2015.7 

PLS3 Expression in Circulating Blood Is a Good Marker for Colon Cancer Recurrence. International conference

Ninth AACR-JCA Joint Conference  2013.2 

臨床応用実現にむけて『食道発癌および癌進展機構解明へのアプローチ』

三森 功士

第20回 日本消化器関連学会  2012.10 

Non-coding RNA, a pivotal role for carcinogenesis and cancer progression

2012.9 

Carcinogenesis associated SNP at 8q24 determines global CNA with poor prognosis in CRC cases International conference

Koshi Mimori, Yasushi Takatsuno, Ken Yamamoto, Hiroshi Inoue, Masaki Mori

2012.6 

遺伝学的因子および疫学環境因子から構築した大腸癌患者および食道癌患者のハイリスク者検出法の確立

三森功士、田中文明、主藤朝也、柴田浩平

第112回日本外科学会  2012.4 

Clinical Significance of mir-144-ZFX Axis in Isolated Tumor Cells in Bone Marrow in Gastric Cancer Cases. International conference

65th Annual Cancer Synposium, SSO  2012.3 

大腸癌原発巣癌細胞における発現遺伝子プロファイルとCGH プロファイルを用いた8q24多型関連発癌および癌進展機構の解明

三森功士、高角康志、井上　裕、田中文明、柴田浩平、杉原 健一、森　正樹

第66回日本消化器外科学会  2011.7 

大腸癌と食道癌の遺伝子多型の臨床的意義

三森功士、田中文明、柴田浩平

'11消化器病大会  2011.6 

EMT Induction by a gene Determines Poorer Prognosis in CRC Cases International conference

Mimori K, Yokobori T, Ishii H, Iwatsuki M, Eguchi H, Klaus Pantel and Mori M

7th Int'l Simposium of Minimal Residual Cancer  2010.9 

臨床応用にむけた消化器癌の真の転移・再発予測因子の同定について

三森功士、深川剛生、横堀武彦、岩槻政晃、飯沼久恵、田原光一郎、笹子 三津留、森　正樹

第64回日本消化器外科学会  2009.7 

大腸癌におけるEMTを制御し造腫瘍能と多分化能を有する遺伝子の臨床的意義と機能解析

三森功士、横堀武彦、岩槻政晃、石丸神矢、秋吉清百合、永原　誠、石井秀始、森　正樹

第18回日本がん転移学会総会  2009.7 

食道癌症例のエキソーム解析および発現遺伝子解析による発癌・癌進展機構の解明 Invited

三森 功士

日本癌学会  2013.9 

家族性食道癌責任領域17q25.1に注目した新規食道癌の原因遺伝子同定へのアプローチ Invited

三森 功士

第19回日本家族性腫瘍学会  2013.11 

Clinical significance of u-PAR gene expression in peripheral blood and bone marrow in breast cancer cases International conference

KoshiMimori, Akemi Kataoka, Norikazu Masuda, Takehiko Yokobori, Masaaki Iwatsuki, Shinji Ohno, Masaki Mori

61th Society of SurgicalOncology  2008.3 

A large-scale study of MT1MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases International conference

Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Etoh T, Sasako M and Mori M

60th Society of Surgical Oncology  2007.3 

日本がん転移学会

日本外科学会

Society of Surgical Oncology

日本がん転移学会

日本大腸肛門病学会

日本再生医療学会

日本乳癌学会

日本臨床外科学会

日本がん分子標的治療学会

American Association for Cancer Research

日本胃癌学会

日本食道学会

日本癌病態治療研究会

日本分子生物学会

The European Liquid Society

日本消化器外科学会   学会賞選考委員、専門医制度委員、評議員選出委員、消化器外科専門医テキスト制作委員、テキスト制作実務委員   Domestic

2023.9 - 2025.8   

日本消化器外科学会   英文誌運営委員長   Domestic

2023.9 - 2025.8   

Councilor   Domestic

2023.8 - 2025.7   

Executive   Domestic

2021.10 - 2023.9   

The European Liquid Biopsy Society   Project Partner   Foreign country

2020.12 - 2025.12   

日本外科学会   代議員   Domestic

2018.6   

Executive   Domestic

2018.6 - 2015.4   

日本外科学会   専門医認定・予備試験委員   Domestic

2018.4 - 2020.3   

日本外科学会   英文誌編集委員会   Domestic

2018.4 - 2020.3   

日本消化器外科学会   教育委員会委員   Domestic

2017.9 - 2019.8   

Councilor   Domestic

2015.5 - 2020.4   

日本消化器外科学会   消化器外科専門医試験作成委員会委員   Domestic

2011.7 - 2018.6   

日本癌病態治療研究会   世話人   Domestic

2011.6 - 2018.6   

日本外科学会   外科専門医試験問題検討委員会   Domestic

2011.4 - 2018.6   

日本がん転移学会   研究奨励賞選考委員会委員   Domestic

2011.4 - 2018.6   

Councilor   Domestic

2010.6 - 2018.6   

日本胃癌学会   プログラム委員   Domestic

2010.5 - 2018.6   

Councilor   Domestic

2010.4 - 2018.6   

日本消化器癌発生学会   会則委員会委員   Domestic

2010.4 - 2018.6   

Councilor   Domestic

2003.4 - 2018.6   

Screening of academic papers

Role(s)： Peer review

2024

司会

第34回日本消化器癌発生学会  （ 群馬 ） 2023.11

座長

第21回日本消化器外科学会大会  （ 神戸 ） 2023.11

座長

第61回日本癌治療学会  （ 横浜 ） 2023.10

創発的研究支援事業アドバイザー

Role(s)： Review, evaluation

国立研究開発法人日本医療研究開発機構  2023.10 - 2024.9

座長 International contribution

第82回日本癌学会  （ 横浜 ） 2023.9

日本消化器外科学会　英文誌運営委員会

2023.9 - 2025.8

座長

慢性便秘症を考える会  （ 大分 ） 2023.7

座長

第32回日本がん転移学会学術集会  （ 仙台 ） 2023.7

司会

第78回日本消化器外科学会学術総会  （ 函館 ） 2023.7

座長

第27回日本がん分子標的治療学会  （ 佐賀 ） 2023.6

司会

第123回日本外科学会  （ 東京 ） 2023.4

令和６年度審査・評価第二部会専門委員

Role(s)： Review, evaluation

独立行政法人日本学術振興会  2023.4 - 2024.3

座長

第7回Liquid Biopsy研究会  （ 東京 ） 2023.1

Screening of academic papers

Role(s)： Peer review

2023

座長

第33回日本消化器癌発生学会  （ 東京 ） 2022.11

独立行政法人日本学術振興会　科学研究費委員会専門委員

Role(s)： Review, evaluation

独立行政法人日本学術振興会  2022.11 - 2023.10

司会

第60回日本癌治療学会  （ 神戸 ） 2022.10

座長

第81回日本癌学会学術総会  （ 横浜 ） 2022.9 - 2022.10

座長

第77回日本消化器外科学会総会  （ 横浜 ） 2022.7

座長

第31回日本がん転移学会  （ 京都 ） 2022.7

群馬大学未来先端研究機関

Role(s)： Review, evaluation

群馬大学未来先端研究機関  2022.7 - 2023.3

日本癌学会喫煙対策委員会

Role(s)： Review, evaluation

日本癌学会  2022.7

モデレーター

第26回がん分子標的治療学会  （ 京都 ） 2022.6 - 2022.7

座長

第31回日本癌病態治療研究会  2022.6

座長

第43回癌免疫外科研究会  （ 京都 ） 2022.5

司会

第122回日本外科学会定期学術集会  （ 熊本 ） 2022.4

熊本大学病院研究活性化プロジェクト審査員

Role(s)： Review, evaluation

熊本大学  2022.3 - 2023.3

金沢大学がん進展制御研究所共同研究運営協議会委員

Role(s)： Review, evaluation

金沢大学  2022.3 - 2023.3

Screening of academic papers

Role(s)： Peer review

2022

司会

第32回日本消化器癌発生学会総会  2021.11

座長

第27回外科侵襲とサイトカイン研究会  2021.10

司会

第40回日本分子腫瘍マーカー研究会  2021.9

消化器外科学会

2021.9 - 2023.6

座長

第30回日本がん転移学会学術集会・総会  2021.7

モデレーター

第25回日本がん分子標的治療学会  2021.5

司会

第121回日本外科学会定期学術集会  2021.4

司会

第18回日本臨床腫瘍学会  2021.2

座長

第5回Liquid Biopsy研究会  2021.1

座長

第16回ＴＲワークショップ  2021.1

座長

第75回日本消化器外科学会総会  2020.12

座長

第31回日本消化器癌発生学会  2020.11

座長

第82回日本臨床外科学会  2020.10

司会

第58回日本癌治療学会  2020.10

座長

第79回日本癌学会学術集会  2020.10

座長

第40回 日本分子腫瘍マーカー研究会  2020.9

司会

第120回日本外科学会定期学術集会  2020.8

司会

第41回癌免疫外科研究会  （ 大阪 ） 2020.7

卓越研究員候補者選考委員会書面審査員及び国際事業委員会書面審査員・書面評価員

Role(s)： Review, evaluation

日本学術振興会  2020.7 - 2021.6

特別研究員等審査会専門委員

Role(s)： Review, evaluation

日本学術振興会  2020.7 - 2021.6

Screening of academic papers

Role(s)： Peer review

2020

オーガナイザー

第42回日本分子生物学会  （ 福岡 ） 2019.12

司会

第30回日本消化器癌発生学会  （ 横浜 ） 2019.11

English Session　座長

第78回日本癌学会  （ 京都 ） 2019.9

座長

第78回日本癌学会  （ 京都 ） 2019.9

司会

第74回日本消化器外科学会総会  （ 東京 ） 2019.7

司会

第28回日本癌病態治療研究会  （ 川越 ） 2019.6

司会

第73回日本食道学会  （ 福岡 ） 2019.6

司会

第40回癌免疫外科研究会  （ 金沢 ） 2019.5

司会

第119回日本外科学会定期学術集会  （ 大阪 ） 2019.4

座長

第29回日本消化器癌発生学会  （ 東京 ） 2018.11

座長 International contribution

第77回日本癌学会学術総会  （ 大阪 ） 2018.9

司会

第73回日本消化器外科学会総会  （ 鹿児島 ） 2018.7

司会

第27回日本病態治療研究会  （ 千葉 ） 2018.5 - 2018.6

司会

第118回日本外科学会定期学術集会  （ 東京 ） 2018.4

日本外科学会英文誌編集委員会

2018.4 - 2020.3

座長

第1回「別府がん若手研究者の勉強会」  （ 別府市 ） 2017.10

座長

ＪＤＤＷ２０１７  （ 福岡 ） 2017.10

座長

第76回日本癌学会学術総会  （ 横浜 ） 2017.9

座長

第26回日本がん転移学会  （ 大阪 ） 2017.7

座長

第72回日本消化器外科学会  （ 金沢 ） 2017.7

司会

第87回大腸癌研究会  （ 四日市 ） 2017.7

座長

第21回日本がん分子標的治療学会  （ 福岡 ） 2017.6

座長

第27回日本サイトメトリー学会  （ 神戸 ） 2017.6 - 2018.6

司会

第26回日本癌病態治療研究会  （ 横浜 ） 2017.6

司会

第38回癌免疫外科研究会  （ 倉敷 ） 2017.5

司会

第117回日本外科学会  （ 横浜 ） 2017.4

座長（Chairmanship）

第89回日本胃癌学会  （ 広島 ） 2017.3

Screening of academic papers

Role(s)： Peer review

2017

司会（Moderator）

第7回癌･炎症と抗酸化研究会（CIA研究会）  （ 大分 ） 2016.11

座長（Chairmanship）

第78回日本臨床外科学会  （ 東京 ） 2016.11

座長（Chairmanship） International contribution

（ 神戸 ） 2016.11

座長（Chairmanship） International contribution

（ 京都 ） 2016.10

座長（Chairmanship）

第75回日本癌学会学術集会  （ 横浜 ） 2016.10

司会（Moderator）

第27回日本消化器癌発生学会  （ 鹿児島 ） 2016.9

次世代がん研究シーズ戦略的育成プログラム　事後評価委員会委員

Role(s)： Review, evaluation

国立研究開発法人　日本医療研究開発機構  2016.9 - 2017.3

座長（Chairmanship）

第20回日本がん免疫学会  （ 大阪 ） 2016.7

座長（Chairmanship）

第26回日本サイトメトリー学会学術集会  （ 福岡 ） 2016.7

司会（Moderator）

第25回日本癌病態治療研究会  （ 千葉 ） 2016.6

司会（Moderator）

第116回日本外科学会  （ 大阪 ） 2016.4

座長（Chairmanship）

第26回日本消化器癌発生学会総会  （ 米子 ） 2015.11

座長（Chairmanship）

ＪＤＤＷ２０１５  （ 東京 ） 2015.10

座長（Chairmanship）

第74回日本癌学会学術総会  （ 名古屋 ） 2015.10

座長（Chairmanship）

第35回日本分子腫瘍マーカー研究会  2015.10

座長（Chairmanship）

第24回日本がん転移学会学術集会  （ 大阪 ） 2015.7

座長（Chairmanship）

第70回日本消化器外科学会  （ 浜松 ） 2015.7

座長（Chairmanship）

第36回癌免疫外科研究回  （ 奄美大島 ） 2015.5

次世代がん研究シーズ戦略的育成プログラム課題プログラムオフィサー

Role(s)： Review, evaluation

国立研究開発法人日本医療研究開発機構  2015.4 - 2016.3

座長（Chairmanship）

第21回外科侵襲とサイトカイン研究会  （ 徳島 ） 2014.12

座長（Chairmanship）

第25回日本消化器癌発生学会総会  （ 福岡 ） 2014.11 - 2015.11

座長（Chairmanship）

第73回日本癌学会学術集会  （ 横浜 ） 2014.9 - 2015.9

サテライトシンポジスト

第16回ＳＮＮＳ研究会  （ 鹿児島 ） 2014.9

座長（Chairmanship）

第52回日本癌治療学会学術集会  （ 横浜 ） 2014.8 - 2015.8

座長（Chairmanship）

第23回日本がん転移学会  （ 金沢 ） 2014.7 - 2015.7

座長（Chairmanship）

第23回日本癌病態治療研究会  （ 岐阜 ） 2014.6 - 2015.6

座長（Chairmanship）

第35回癌免疫外科研究会  （ 大阪 ） 2014.5 - 2015.5

座長（Chairmanship）

第114回日本外科学会定期学術集会  （ 京都 ） 2014.4

座長（Chairmanship）

第21回日本がん転移学会学術集会・総会  （ 広島 ） 2013.7

座長（Chairmanship）

第16回日本がん分子標的治療学会  （ 福岡 ） 2013.6

座長（Chairmanship）

第74回日本臨床外科学会総会  （ 東京 ） 2012.11 - 2012.12

座長（Chairmanship）

第71回日本癌学会学術総会  （ 札幌 ） 2012.9

文部科学省 研究振興局 学術研究助成課　 学術調査官

Role(s)： Review, evaluation

文部科学省  2012.8 - 2014.7

座長（Chairmanship）

第112回日本外科学会  （ 千葉 ） 2012.4

座長（Chairmanship）

第70回日本癌学会  2011.10

座長（Chairmanship）

第51回日本消化器病学会  （ 京都国際会議場 ） 2009.10

科学研究費委員会専門委員

Role(s)： Review, evaluation

2008.12 - 2010.11

座長（Chairmanship）

第66 回日本癌学会学術総会  2007.10 - Present

座長（Chairmanship）

第62回日本消化器外科学会  （ 東京大学大学院消化管外科学・上西紀夫教授・京王プラザホテル ） 2007.7 - Present

座長（Chairmanship）

日本癌学会  （ 福岡 ） 2004.10 - Present

座長（Chairmanship）

日本消化器外科学会  （ 鹿児島 ） 2004.7 - Present

細胞内外エフェクターに対する大腸がん細胞の適応システムの包括的解析と新規免疫療法の開発

Grant number：24jm0210108s0202  2023 - 2027

科学研究費助成事業  AMED 医療分野国際科学技術共同研究開発推進事業

オールジャパン体制による食道がん等消化器難治がんの全ゲノム配列データ及び臨床情報による先端的創薬開発・全ゲノム医療基盤構築

2023 - 2026

科学研究費助成事業  AMED革新的がん医療実用化研究事業

メチル化ctDNAによる大腸がん根治術後再発早期診断の実装的モニタリング法の開発

Grant number：23K06765  2023 - 2025

日本学術振興会  科学研究費助成事業  基盤研究(C)

膵がん微小環境を構築する細胞社会において免疫寛容に寄与するがん代謝機構の解明

Grant number：23K08215  2023 - 2025

日本学術振興会  科学研究費助成事業  基盤研究(C)

転写産物のロングリード・シーケンスによる食道癌化学放射線療法抵抗性獲得機構の解明

Grant number：23K07066  2023 - 2025

日本学術振興会  科学研究費助成事業  基盤研究(C)

陥凹型早期癌のオルガノイドを用いた大腸癌浸潤・転移の再現と機序解明

2023 - 2025

日本学術振興会  科学研究費助成事業  基盤研究(C)

空間的シングルセル解析による大腸腺腫から発がん過程に於ける免疫寛容獲得機構の解明

Grant number：23K08074  2023 - 2025

日本学術振興会  科学研究費助成事業  基盤研究(C)

時・空間的シングルセル解析による膵がん細胞の悪性度獲得機構の解明と治療標的の同定

Grant number：22K08894  2023 - 2025

日本学術振興会  科学研究費助成事業  基盤研究(C)

VISIUMによる乳がん転移阻害剤プロパゲルマニウムによる免疫能賦活化誘導機構の解明

Grant number：23K06698  2023 - 2025

日本学術振興会  科学研究費助成事業  基盤研究(C)

個別化デジタルPCRによる超高感度腫瘍由来循環DNAモニタリング

Grant number：23ck0106825h0001  2023 - 2025

科学研究費助成事業  AMED革新的がん医療実用化研究事業

肝がんの分化規定遺伝子の同定と革新的治療法の開発（

2022 - 2025

日本学術振興会  科学研究費助成事業  基盤研究(C)

大腸がん細胞と共局在により悪性度と免疫寛容を獲得するがん微小環境の解明

Grant number：22H02903  2022 - 2024

日本学術振興会  科学研究費助成事業  基盤研究(B)

空間的シングルセル解析による大腸がん転移巣を形成するがん微小環境の解明

2022 - 2024

日本学術振興会  科学研究費助成事業  基盤研究(C)

固形癌における抗腫瘍薬の薬剤耐性を改善するグルタミン代謝抑制化合物の開発

Grant number：22K09006  2022 - 2024

日本学術振興会  科学研究費助成事業  基盤研究(C)

タイプ別胃癌の誘因と発癌・進展における分子機序および免疫応答メカニズムの解明

2022 - 2024

日本学術振興会  科学研究費助成事業  基盤研究(C)

空間的遺伝子発現解析を用いた食道癌CRT抵抗性に関わる免疫微小環境の検討

Grant number：22K07774  2022 - 2024

日本学術振興会  科学研究費助成事業  基盤研究(C)

肝内胆管癌多層オミックス解析と機械学習によるリポジショニング薬の同定

Grant number：22K08826  2022 - 2024

日本学術振興会  科学研究費助成事業  基盤研究(C)

難治性がんにおけるエピジェネティックな多様性・環境適応創生機構の解明に基づく新たな治療法開発

2022 - 2024

科学研究費助成事業  AMED次世代がん医療加速化研究事業

膵がん組織内の腫瘍含有率を、デジタルPCRを用いたKRAS等変異アリル頻度から推定する研究

2021.12 - 2023.3

共同研究

遺伝子の臨床検体による層別化能の検証